CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

48 hedge funds and large institutions have $78.7M invested in Concert Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.4M
2
+$9.24M
3
+$8.31M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.86M
5
WSA
Wall Street Associates
California
+$4.32M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$467K
27
$432K
28
$355K
29
$351K
30
$341K
31
$325K
32
$251K
33
$229K
34
$218K
35
$206K
36
$198K
37
$174K
38
$163K
39
$159K
40
$155K
41
$91K
42
$77K
43
$54K
44
$32K
45
$22K
46
$13K
47
$13K
48
$4K
1
2